Clinical trial
A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the…
NCT00247364 · Sleep Health Centers, Other · Completed
Key facts
| NCT number | NCT00247364 |
|---|---|
| Title | A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS) |
| Official title | A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS) |
| Lead sponsor | Sleep Health Centers, Other |
| Collaborators | UCB Pharma Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Restless Legs Syndrome |
| Intervention type | Drug |
| Interventions | Levetiracetam (Keppra) |
| Enrollment | 20 |
| Start date | Nov 1, 2003 |
| Completion | Oct 1, 2005 |
| First posted | Nov 1, 2005 |
| Last update posted | Nov 1, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: